Search research articles
Contact Us
Filters
Showing results (381-390 of 449) with videos related to
Page
of 45
Sort By:
Neurology. Clinical Practice
|
January 29, 2021
Lymphocyte reconstitution after DMF discontinuation in clinical trial and real-world patients with MS
Andrew Chan, John Rose, Enrique Alvarez, et al.
Journal of Psychosomatic Research
|
January 7, 2023
Co-prevalence and incidence of myocardial infarction and/or stroke in patients with depression and/or anxiety: A systematic review and meta-analysis
Phoebe Yue Aw, Xian Zheng Pang, Caitlin Fern Wee, et al.
Journal of Hospital Medicine
|
February 10, 2026
Improving sleep on the inpatient general, non-stroke neurology service: A quasi-experimental interventional trial
Noor F Shaik, Lydia Denison, G M Anya Venezia, et al.
The Journal of General Virology
|
October 6, 2025
Immunogenicity of a trivalent haemorrhagic fever vaccine candidate against Sudan virus, Marburg virus and Lassa virus in an mpox vaccine
Martina Pfranger, Nina Krause, Benedikt Asbach, et al.
Clinical Neurology and Neurosurgery
|
July 28, 2020
Patients with a depressive and/or anxiety disorder can achieve optimum Long term outcomes after surgery for grade 1 spondylolisthesis: Analysis from the quality outcomes database (QOD)
Osama Kashlan, Kevin Swong, Mohammed Ali Alvi, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
December 19, 2014
Natalizumab-related anaphylactoid reactions in MS patients are associated with HLA class II alleles
Belén de la Hera, Elena Urcelay, David Brassat, et al.
The Lancet. Rheumatology
|
September 13, 2021
Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study
Matthias B Moor, Franziska Suter-Riniker, Michael P Horn, et al.
Biorxiv : the Preprint Server for Biology
|
January 7, 2025
Pathway Polygenic Risk Scores (pPRS) for the Analysis of Gene-environment Interaction
W James Gauderman, Yubo Fu, Bryan Queme, et al.
European Journal of Neurology
|
December 17, 2024
Switching from natalizumab to antiCD20 monoclonal antibodies: Short transition interval is associated with improved outcome
Gabriel Bsteh, Robert Hoepner, Jonathan A Gernert, et al.
Plos Genetics
|
August 5, 2025
Pathway polygenic risk scores (pPRS) for the analysis of gene-environment interaction
W James Gauderman, Yubo Fu, Bryan Queme, et al.
Page
of 45
Search research articles
Search
Showing results (381-390 of 449) with videos related to
Sort By:
Page
of 45
Neurology. Clinical Practice
|
January 29, 2021
Lymphocyte reconstitution after DMF discontinuation in clinical trial and real-world patients with MS
Andrew Chan, John Rose, Enrique Alvarez, et al.
Journal of Psychosomatic Research
|
January 7, 2023
Co-prevalence and incidence of myocardial infarction and/or stroke in patients with depression and/or anxiety: A systematic review and meta-analysis
Phoebe Yue Aw, Xian Zheng Pang, Caitlin Fern Wee, et al.
Journal of Hospital Medicine
|
February 10, 2026
Improving sleep on the inpatient general, non-stroke neurology service: A quasi-experimental interventional trial
Noor F Shaik, Lydia Denison, G M Anya Venezia, et al.
The Journal of General Virology
|
October 6, 2025
Immunogenicity of a trivalent haemorrhagic fever vaccine candidate against Sudan virus, Marburg virus and Lassa virus in an mpox vaccine
Martina Pfranger, Nina Krause, Benedikt Asbach, et al.
Clinical Neurology and Neurosurgery
|
July 28, 2020
Patients with a depressive and/or anxiety disorder can achieve optimum Long term outcomes after surgery for grade 1 spondylolisthesis: Analysis from the quality outcomes database (QOD)
Osama Kashlan, Kevin Swong, Mohammed Ali Alvi, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
December 19, 2014
Natalizumab-related anaphylactoid reactions in MS patients are associated with HLA class II alleles
Belén de la Hera, Elena Urcelay, David Brassat, et al.
The Lancet. Rheumatology
|
September 13, 2021
Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study
Matthias B Moor, Franziska Suter-Riniker, Michael P Horn, et al.
Biorxiv : the Preprint Server for Biology
|
January 7, 2025
Pathway Polygenic Risk Scores (pPRS) for the Analysis of Gene-environment Interaction
W James Gauderman, Yubo Fu, Bryan Queme, et al.
European Journal of Neurology
|
December 17, 2024
Switching from natalizumab to antiCD20 monoclonal antibodies: Short transition interval is associated with improved outcome
Gabriel Bsteh, Robert Hoepner, Jonathan A Gernert, et al.
Plos Genetics
|
August 5, 2025
Pathway polygenic risk scores (pPRS) for the analysis of gene-environment interaction
W James Gauderman, Yubo Fu, Bryan Queme, et al.
Page
of 45